Myriad Genetics vs Neogen: revenue, profit, margins and growth compared
Myriad Genetics brought in $824.5M of revenue in fiscal 2025, Neogen $870.4M in fiscal 2026. Revenue changed by -1.6% at Myriad Genetics and -2.7% at Neogen on the year before, so Myriad Genetics grew faster. Myriad Genetics kept -44.4% of its revenue as net profit, Neogen -0.9%.
Fiscal years as each company reports them; the two may end in different months.
Questions about Myriad Genetics and Neogen
Which is bigger by revenue, Myriad Genetics or Neogen?
Neogen is bigger by revenue: $870.4M in fiscal 2026, against $824.5M for Myriad Genetics in fiscal 2025.
Which keeps more of its revenue as profit, Myriad Genetics or Neogen?
Myriad Genetics had a net margin of -44.4% in fiscal 2025; Neogen had -0.9% in fiscal 2026.
Which grew revenue faster, Myriad Genetics or Neogen?
In their latest fiscal years revenue changed by -1.6% at Myriad Genetics and -2.7% at Neogen.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.